Strategic Acquisition of Lucira Health by Pfizer Indicates a Promising Future for COVID-19 Testing
In some exciting news, Pfizer, the well-known pharmaceutical company, has made a noteworthy acquisition by purchasing the struggling company Lucira, which specializes in COVID-19 testing. This unexpected move by Pfizer has caught people's attention, especially considering Lucira's financial difficulties.
Moreover, the availability of Lucira's COVID-19 tests has become limited since their production has been temporarily halted. However, despite these circumstances, there is still hope, as the team here at PPE Supply Canada is constantly working hard to ensure we have Lucira’s rapid tests in stock and available at all times, for all of our customers!
Let's explore why Pfizer acquired Lucira and what it means for the future of COVID-19 testing.
Lucira Health to Help Pfizer Strengthen the Company’s Testing Capabilities
Lucira Health is known for developing rapid COVID-19 tests with PCR-quality accuracy that provide reliable results within 30 minutes or less, and Pfizer's acquisition of Lucira Health shows its commitment to bolstering its testing capabilities. By incorporating Lucira's advanced testing technology, Pfizer aims to improve its position in the market and offer a wide range of testing solutions to meet the growing demand for convenient, at-home testing.
Lucira’s Testing Technology to Help Pfizer Diversify Product Portfolio with Rapid Tests
The acquisition of Lucira Health aligns with Pfizer's strategy to diversify its product portfolio. By integrating Lucira's testing technology, Pfizer can expand beyond vaccines and therapeutics. This diversification allows Pfizer to take a more comprehensive approach to combat the aftermath of the COVID-19 pandemic by providing complementary testing solutions alongside its existing products.
Lucira COVID-19 Test & COVID-19 & Flu Test Available at PPE Supply Canada
While finding Lucira’s COVID-19 tests may seem challenging due to their temporary halt in production, PPE Supply Canada shines through for their customers, working hard to ensure the consistent availability of Lucira’s tests in addition to offering extremely fast delivery times!
We’re proud to offer Lucira test kits to Canadian and US markets, ensuring the health and safety of communities near and far. We know when you need a COVID-19 or flu test, you need it now, which is why we offer only the fastest delivery options at affordable rates for all of our customers. Our team here at PPE Supply Canada is constantly striving to ensure the health and safety of our valued clients!
You can trust us to have Lucira Health’s rapid tests always in stock and ready to be shipped!
Extended Expiry Date for Lucira COVID-19 & Flu Tests
Lucira Health has authorized the extended use of their COVID-19 & Flu test for up to six (6) months after their stated expiration date, providing a prolonged window for their utilization. For COVID-19 tests, manufacturers are required to label products based on real-time stability studies and Lucira Health completed the real-time stability testing to support an 18-month shelf life for their COVID-19 and Flu test.
CONCLUDING THOUGHTS
Pfizer’s acquisition of the bankrupt Lucira Health proves significant influence over the future of COVID-19 testing.
Despite the current limited availability of Lucira’s COVID-19 and COVID-19 and flu tests, this acquisition reflects Pfizer’s commitment to expanding its testing capabilities in addition to diversifying its product offerings, ultimately catering to a wider audience. By incorporating Lucira Health's innovative testing technology, Pfizer aims to strengthen its position in the market and provide comprehensive solutions for combating COVID-19.
We hope that our work in striving to provide Lucira’s rapid tests to our valued customers shows our own commitment to keeping our communities safe. Whether you’re experiencing symptoms or just playing it safe, we’ve always got you covered!
